Central Chondrosarcoma, Grade 2
1 clinical trials · Condition
◉ Watch Central Chondrosarcoma, Grade 2
| Record | Firm | Date |
|---|---|---|
| Testing Atezolizumab in People 2-17 Years Old With Clear Cell Sarcoma or Advanced Chondrosarcoma (NCT04458922) | National Cancer Institute (NCI) | 2020-10-05 |
Track Central Chondrosarcoma, Grade 2 automatically
Every clearance here is in the API, with alerts when new ones post.